This course is FREE with Unlimited CE!

Choose from two Unlimited CE subscription options and get access to 1000+ CE and professional development courses.

Get access starting at $49.95/yrLoading..

Goals and Learning Outcomes

Inflammatory bowel disease (IBD) is a chronic disorder involving an abnormal immune reaction to specific components of the gastrointestinal (GI) tract. The two primary forms of IBD are Crohn’s disease (CD) and ulcerative colitis (UC). In the U.S., approximately 3.1 million people have been diagnosed with one of these two forms of IBD (CDC, 2022).


After taking this course, you should be able to:

  • Identify the role of clinical presentation and IBD severity in pharmacological treatment decision making.
  • Identify two classes of drugs for the management of IBD.
  • Recall the indications, contraindications, and common adverse effects of drugs used to treat IBD.

Course Termination Date: Not yet determined

Content Expiration Date: 12/31/26

Course Originally Released On: 07/01/23

Course Authors

4.4 Average

Course Reviews

7017 reviews

Accreditation Information

Nurse.com Accreditation

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, Kansas State Board of Nursing, Kentucky Board of Nursing, Michigan Board of Nursing, Mississippi Board of Nursing, New Hampshire Board of Nursing, New Mexico Board Of Nursing, North Dakota Board of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Registered Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.